Drug firm Pfizer on Friday said its net profit declined by 2 per cent to Rs 128 crore for the third quarter ended December 31, 2024.

Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

Swiss pharmaceutical giant Novartis (NVS) on Friday reported forecast-beating quarterly sales as its clutch of heart failure to breast cancer ...

Bernstein analyst Courtney Breen maintained a Hold rating on Pfizer (PFE – Research Report) yesterday and set a price target of $32.00. The ...

David Werner Real Estate Investments and Metro Loft Management will redevelop two buildings into more than 1,600 units.

The former President of Pfizer Global Manufacturing gifted $50 million to his former school, Northfield Mount Hermon.

HonorHealth announced the creation of its new international Center for Translational Science. Sanofi said it will repurchase $5.2 billion of stock and grow profits faster this year as the drugmaker ...

"Pfizer just released its list of side effects of its COVID-19 vaccine," multiple Facebook posts said Jan. 26 and 27. The posts included a purported list of 46 Pfizer-BioNtech COVID-19 vaccine side ...

Weight-loss drugs are transforming health care and Wall Street, but exciting prospects don’t necessarily mean a company is a good investment.

Pfizer's PFE short percent of float has risen 20.9% since its last report. The company recently reported that it has 91.78 million shares sold short, which is 1.62% of all regular ...

Petra Capital raises $270 million for fifth growth fund, Northwind Group funds $135 million Pfizer HQ conversion loan.

Pfizer Inc. (NYSE:PFE), one of the world's largest pharmaceutical companies with a market capitalization of $151.25 billion, finds itself at a critical juncture as it navigates the post-pandemic ...